Rudolf Valenta is an expert in Immunology at Vienna General Hospital (Austria). As of October 2026, ScienceLeadR ranks Rudolf Valenta in the top 1% of experts worldwide for Hypersensitivity, Rhinitis and Nose Diseases. Rudolf Valenta has authored 841 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 1 of them ongoing. SLR score: 3,017 (community average: 125). How the SLR is computed.

LeadR Profile

Rudolf Valenta Vienna General Hospital Austria
3 017 ScienceLeadR Reputation 3017
Network Map

Immunology

Subspecialties: Biochemistry - Allergy - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1991 - 2026

Source: PubMed

Medical University of Vienna

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 841

Citations

Citations: 48 114 1st author: 54 Last author: 298 Unique author: 8


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Heterologous Expression and Immunoreactivity of Wheat Amylase-Trypsin Inhibitors.
PMID 42884101 — amylases, trypsin, trypsin inhibitors
Int J Mol Sci20260
Pre-Seasonal Treatment With Recombinant Carrier-Based Birch Vaccine Improves Birch Pollen Allergy.
PMID 42695588 — injections, vaccines, hypersensitivity, rhinitis, allergic, seasonal, basophils, allergens, therapeutics, allergy
Allergy20261
IgE Occupancy and Antigen Valency Cooperate to Control FcεRI Aggregation Geometry and Signaling Efficiency.
PMID 42589421 — cells, hypersensitivity, allergens, mast cells, allergy
Int J Mol Sci20260
Involution of IgE sensitization to house dust mite allergen molecules by age.
PMID 42324647 — dust, hypersensitivity, aging, allergens, immune system diseases, diagnosis, rhinitis, asthma
Pediatr Allergy Immunol20261
Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.
PMID 42045018 — environmental exposure, occupational health, allergens, occupational exposure, irritants, asthma, environmental health
Occup Environ Med20260

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1 Study Chair: 1 Study Director: 1

By phase:

N/A 4
Phase 2 2
Phase 1 1
Phase 1/Phase 2 1

By status:

Completed 6
Recruiting 1
Unknown 1

By type:

Interventional 7
Observational 1

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Contribution of Nasal IgE Production to the Boost of Systemic Allergen specific IgE Upon Nasal Allergen Contact
NCT05042830 — cytokines, eye, skin, pilot projects, cells, research design, flow cytometry, pregnancy tests, pilots, pregnancy, microscopy, confocal, blood, serum, hypersensitivity, ear, biopsy, allergens, solutions, signs and symptoms, microscopy, immune system diseases, diagnosis, nasal sprays, punctures, nose, pharynx, veins, rna
N/ARecruiting2021

LeadR Networks

Main global connection map